Home > Insider Trading > Filing (0000950170-24-066078)

Filing Details

Accession Number:: 0000950170-24-066078
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-05-29 17:19:46
Reporting Period:: 2024-05-24

Accepted Time:: 2024-05-29 17:19:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1845257	Lifestance Health Group Inc.	LFST	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1634415	Summit Partners Growth Equity Fund Ix-A, L.p.	Summit Partners, 222 Berkeley St Fl 18 Boston MA 02116	No	No	No	No
1634426	Summit Partners Growth Equity Fund Ix-B, L.p.	Summit Partners, 222 Berkeley St Fl 18 Boston MA 02116	No	No	No	No
1654074	Summit Investors Ge Ix/Vc Iv, Llc	222 Berkeley Street, 18Th Floor Boston MA 02116	No	No	No	No
1660981	Summit Partners Entrepreneur Advisors Fund Ii, L.p.	222 Berkeley Street, 18Th Floor Boston MA 02116	No	No	No	No
1846709	Summit Investors Ge Ix/Vc Iv (Uk), L.p.	222 Berkeley Street, 18Th Floor Boston MA 02116	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-05-24	3,802,345	$5.89	41,932,358	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents 2,328,399 shares sold by Summit Partners Growth Equity Fund IX-A, L.P., 1,453,820 shares sold by Summit Partners Growth Equity Fund IX-B, L.P., 16,253 shares sold by Summit Investors GE IX/VC IV, LLC, 2,173 shares sold by Summit Partners Entrepreneur Advisors Fund II, L.P., and 1,700 shares sold by Summit Investors GE IX/VC IV (UK), L.P.
Represents 25,677,643 shares held by Summit Partners Growth Equity Fund IX-A, L.P., 16,032,765 shares held by Summit Partners Growth Equity Fund IX-B, L.P., 179,239 shares held by Summit Investors GE IX/VC IV, LLC, 23,961 shares held by Summit Partners Entrepreneur Advisors Fund II, L.P., and 18,750 shares held by Summit Investors GE IX/VC IV (UK), L.P.
Summit Partners, L.P. is the managing member of Summit Partners GE IX, LLC, which is general partner of Summit Partners GE IX, LP, which is the general partner of Summit Partners Growth Equity Fund IX-A, L.P. and Summit Partners Growth Equity Fund IX-B, L.P. Summit Master Company, LLC is (i) the sole member of Summit Partners Entrepreneur Advisors GP II, LLC, which is the general partner of Summit Partners Entrepreneur Advisors Fund II, L.P. and (ii) the managing member of Summit Investors Management, LLC, which is the manager of Summit Investors GE IX/VC IV, LLC, and the general partner of Summit Investors GE IX/VC IV (UK), L.P.
Summit Master Company, LLC, as the sole member of Summit Partners Entrepreneur Advisors GP II, LLC and the managing member of Summit Investors Management, LLC, has delegated investment decisions, including voting and dispositive power, to Summit Partners, L.P. and its investment committee responsible for voting and investment decisions with respect to LifeStance Health Group, Inc. Summit Partners, L.P., through a three-person investment committee, currently composed of Peter Y. Chung, Mark A. deLaar and Craig D. Frances, has voting and dispositive authority over the shares held by each of these entities and therefore beneficially owns such shares. Each of the Summit Funds, Mr. Chung, Mr. deLaar and Dr. Frances disclaim disclaims beneficial ownership of the shares, except, in each case, to the extent of such person's or entity's pecuniary interest therein.